Jamie Holloway

Jamie Holloway, PhD has extensive experience in the field of cancer research and advocacy. They have held various roles in different companies and organizations.

From 2019 to present, Holloway has been working at Caris Life Sciences, starting as a Molecular Science Liaison and later progressing to the Senior Director and currently the Area Vice President of Molecular Science Liaisons.

In 2013, Holloway began working as a Breast Cancer Advocate independently, providing support and raising awareness for breast cancer. They also served as a Consumer Reviewer for the Department of Defense Breast Cancer Research Program and the New York Department of Health Peter T. Rowley Breast Cancer Program, providing feedback and insights for research projects.

As a self-employed Consultant, Holloway has been involved in public speaking engagements and media interviews to educate and support individuals affected by cancer.

Holloway has also served as a Patient Advocate for the Broad Institute of MIT and Harvard, supporting and providing resources to volunteers and participants in the Metastatic Breast Cancer Project.

Additionally, they have worked as a Clinical Research Advocate at Science 37 and as a Precision Medicine Advocate at Cure Forward.

Holloway has also contributed as a Freelance Writer for the CURE Media Group, sharing their expertise and experiences in the cancer community.

Overall, Holloway's work experience highlights their expertise in cancer research, advocacy, and patient support.

Jamie Holloway, PhD pursued a Bachelor of Science (B.S.) in Biochemistry from the University of Illinois at Urbana-Champaign, completing the degree between the years 1995 and 1999. Following this, Jamie furthered their studies by enrolling at Georgetown University from 1999 to 2004, where they successfully obtained a Doctor of Philosophy (PhD) in Tumor Biology.